<?xml version="1.0" ?><text author="Chad Brenner" dateCollected="2019-11-03" id="autogum_academic_doc517" shortTile="applications-bioinformatics" sourceURL="https://www.mdpi.com/2072-6694/11/11/1630/htm" speakerCount="0" speakerList="none" title="Applications of Bioinformatics in Cancer" type="academic">
<p>
<s>
This
series
of
25
articles
(
22
original
articles
,
3
reviews
)
is
presented
by
international
leaders
in
bioinformatics
and
biostatistics
.
</s>
<s>
This
original
series
of
articles
details
emerging
approaches
that
leverage
artificial
intelligence
and
machine
learning
algorithms
to
improve
the
utility
of
bioinformatics
applications
in
cancer
biology
.
</s>
<s>
Importantly
,
the
issue
also
addresses
the
limitations
of
current
approaches
to
analyzing
high
throughput
datasets
by
providing
support
for
novel
methods
that
can
be
used
to
improve
complex
multi-variable
analysis
.
</s>
<s>
For
example
,
in
order
to
help
identify
clinically
meaningful
genes
,
Shen
et
al.
</s>
<s>
demonstrate
how
the
implementation
of
a
knockoff
procedure
can
control
false
discovery
rates
in
next-generation
datasets
with
relatively
small
sample
sizes
.
</s>
<s>
Additionally
,
tools
were
developed
and
validated
to
address
complex
problems
ranging
from
tumor
heterogeneity
to
mutation
signature
analysis
.
</s>
<s>
For
example
,
intertumor
heterogeneity
scores
were
characterized
from
&gt;2800
tumors
and
used
to
identify
genes
associated
with
high
heterogeneity
including
histone
methyltransferase
<hi rend="italic">
SETD2
</hi>
and
DNA
methyltransferase
<hi rend="italic">
DNMT3A
</hi>
,
which
were
then
validated
by
CRISPR/CAS9
in
experimental
systems
.
</s>
<s>
Likewise
,
a
tool
was
derived
to
infer
tumor
RNA
expression
signatures
of
genes
with
copy
loss
to
support
gene-loss
driven
biomarker
analysis
,
and
,
a
weight-matrix
based
approach
was
used
to
highlight
the
distribution
of
APOBEC
and
AID-related
gene
signatures
in
multiple
cancers
that
drive
subsets
of
the
somatic
mutation
spectra
.
</s>
<s>
Together
these
manuscripts
demonstrate
how
novel
tools
and
statistical
approaches
are
being
used
to
refine
analysis
of
large
next
generation
sequencing
datasets
.
</s>
<s>
Extending
these
concepts
,
Veronesi
et
al.
also
develop
an
R-script
based
tool
box
for
efficient
analysis
of
gene
signatures
with
diagnostic
and
prognostic
variable
that
highlights
how
tools
are
being
rapidly
adapted
into
easy-to-use
application
packages
.
</s>
</p>
<p>
<s>
Several
papers
in
this
series
also
demonstrate
the
potential
to
integrate
large
and
diverse
datasets
and
use
machine
learning
approaches
to
develop
significantly
improved
multi-variable
predictors
of
clinical
outcome
.
</s>
<s>
For
example
,
deep
learning
artificial
intelligence-based
approaches
were
shown
to
be
highly
effective
at
integrating
genomic
data
from
multiple
sources
using
de-noising
auto-encoders
to
curate
deep
features
associated
with
breast
cancer
clinical
characteristics
and
outcomes
.
</s>
<s>
Moreover
,
artificial
intelligence-driven
classification
techniques
were
also
used
on
multiple
independent
colorectal
cancer
datasets
to
identify
and
verify
biomarkers
of
diagnosis
and
prognosis
that
may
have
important
implications
for
the
disease
.
</s>
<s>
As
another
example
,
the
Taiwan
Cancer
Registry
database
was
analyzed
to
evaluate
the
value
of
the
Wu
co-morbidity
score
for
accuracy
in
assessing
curative-surgery-related
90-day
mortality
risk
and
overall
survival
in
patients
with
locoregionally
advanced
head
and
neck
cancer
;
and
,
in
an
alternative
approach
,
Ferroni
et
al.
demonstrate
the
utility
of
using
machine
learning-driven
decision
support
systems
to
extract
data
from
electronic
health
records
and
refine
prognostic
variables
.
</s>
<s>
As
an
alternative
approach
,
and
to
understand
how
gene
sets
may
correlate
with
outcome
,
Locati
et
al.
utilized
self-organizing
map
approaches
to
curate
publicly
available
HPV+
cancer
data
and
inferred
gene
signatures
associated
with
three
biological
subtypes
of
the
disease
.
</s>
<s>
Novel
datasets
comparing
the
molecular
composition
of
primary
colorectal
cancer
and
brain
metastases
were
also
generated
.
</s>
<s>
In
an
interesting
informatics
approach
,
analysis
of
steroid
hormone-related
gene
sets
in
publicly
available
data
identified
steroidogenic
acute
regulatory
protein
as
a
potential
prognostic
biomarker
in
breast
cancer
.
</s>
<s>
Likewise
,
a
meta-analysis
of
GEO
and
TCGA
miRNA
datasets
led
to
the
prioritization
of
candidate
biomarkers
of
prognosis
and
overall
survival
in
oral
cancer
.
</s>
<s>
Machine
learning
approaches
were
similarly
used
to
prioritize
relevant
miRNAs
and
validate
the
high
performance
of
highly
ranked
miRNAs
in
classification
models
,
suggesting
that
prioritization
of
targets
from
expression
data
is
a
highly
effective
strategy
.
</s>
<s>
Analysis
of
miRNA
data
using
an
observed
survival
interval
was
reported
to
overcome
issues
with
clinical
outcome
associations
.
</s>
<s>
Collectively
suggesting
the
potential
of
these
approaches
in
this
new
era
of
machine
learning
approaches
.
</s>
<s>
Finally
,
additional
analysis
of
similar
datasets
also
highlighted
the
role
of
detailed
characterization
of
clinical
characteristics
in
avoiding
biological
and
the
clinical
outcome
analysis
bias
in
large
dataset
analysis
was
well
demonstrated
in
the
analysis
of
pancreatic
cancer
TCGA
data
by
Nicolle
et
al.
.
</s>
</p>
<p>
<s>
More
broadly
,
machine
learning-driven
informatics
approaches
,
which
were
demonstrated
to
have
utility
in
improving
statistical
analysis
of
integrated
histopathologic
datasets
,
were
implemented
to
analyze
the
TCGA
lung
adenocarcinoma
dataset
as
an
alternative
approach
to
modeling
outcomes
.
</s>
<s>
Furthermore
,
using
both
the
lung
adenocarcinoma
and
hepatocellular
carcinoma
datasets
to
analyze
the
utility
of
integrated
gene
and
imaging
data
,
multiple
individual
genes
,
conditional
on
imaging
features
,
were
shown
to
drive
significant
improvement
in
prognosis
modeling
.
</s>
<s>
These
improvements
in
integrated
multi-feature
image
analysis
and
molecular
analysis
for
outcome
modeling
suggest
that
complex
models
incorporating
diverse
variables
may
be
key
to
making
substantial
improvements
to
clinical
outcome
models
in
the
future
.
</s>
</p>
</text>